Filing Flows › RxSight (RXST) › Q1 2026
RxSight (RXST) Q1 2026 earnings results (first quarter 2026)
10-Q filed May 6, 2026
RxSight (RXST) reported revenue of $30.9M for the first quarter 2026 (Q1 2026), -18% from a year earlier and -5% from the quarter before. Operating margin was -57.7%, net loss $15.9M (51.4% of revenue).
RxSight, Q1 2026: revenue $30.9M (-18% year over year), operating margin -57.7%, net loss $15.9M, operating cash flow −$10.9M. The chart follows the revenue to costs, profit and cash.
| Q1 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $30.9M | -5% | -18% |
| Operating profit | −$17.8M | — | — |
| Net earnings | −$15.9M | — | — |
| Operating cash flow | −$10.9M | — | — |
What changed
Revenue was $30.9M in Q1 2026, down 18% year over year and down 5% from the previous quarter. Rxlal was the largest line at 88% of revenue. LDD lost $7.0M year over year (down 75%), 101% of the total change.
Gross margin was 76.1%, up 1.3 points from Q1 2025. Operating costs exceeded revenue by $17.8M, an operating margin of -57.7%. Operating expenses grew 6% against a revenue fall of 18%. The fastest-growing cost line was SG&A (+11%). The quarter ended with a net loss of $15.9M, wider than the previous quarter's $9.2M loss.
Operating cash flow was −$10.9M. Non-cash charges added back $834K of depreciation and amortization and $7.9M of share-based compensation. Working capital and other items used $3.8M. Capital expenditures of $759K exceeded it, leaving free cash flow of −$11.7M.
Questions
What was RxSight's revenue in the first quarter 2026?
RxSight (RXST) reported revenue of $30.9M for the first quarter 2026 (Q1 2026), -18% from a year earlier and -5% from the quarter before.
Was RxSight profitable in the first quarter 2026?
Operating loss was $17.8M (-57.7% of revenue) and net loss $15.9M.
Source: RxSight 10-Q on SEC EDGAR.